1-methyl-1H-1,3-benzodiazole-2-carbaldehyde → 1-cyclopentyl-6-{(3S,4S)-4-methyl-1-[(1-methyl-1H-benzimidazol-2-yl)methyl]pyrrolidin-3-yl}-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one

HRID 2424777Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2424777
[CH:1]1([N:6]2[C:10]3[N:11]=[C:12]([C@H:16]4[C@H:20]([CH3:21])[CH2:19][NH:18][CH2:17]4)[NH:13][C:14](=[O:15])[C:9]=3[CH:8]=[N:7]2)[CH2:5][CH2:4][CH2:3][CH2:2]1.[CH3:22][N:23]1[C:27]2[CH:28]=[CH:29][CH:30]=[CH:31][C:26]=2[N:25]=[C:24]1[CH:32]=O>>[CH:1]1([N:6]2[C:10]3[N:11]=[C:12]([C@H:16]4[C@H:20]([CH3:21])[CH2:19][N:18]([CH2:32][C:24]5[N:23]([CH3:22])[C:27]6[CH:28]=[CH:29][CH:30]=[CH:31][C:26]=6[N:25]=5)[CH2:17]4)[NH:13][C:14](=[O:15])[C:9]=3[CH:8]=[N:7]2)[CH2:5][CH2:4][CH2:3][CH2:2]1

Komponenten

3

Edukt 2

HCID 7620841-methyl-1H-1,3-benzodiazole-2-carbaldehydeHCID 1361284551-cyclopentyl-6-[(3S,4S)-4-methylpyrrolidin-3-yl]-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one

Produkt 1

HCID 1358759051-cyclopentyl-6-{(3S,4S)-4-methyl-1-[(1-methyl-1H-benzimidazol-2-yl)methyl]pyrrolidin-3-yl}-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one

Versuchsvorschrift

Following the procedure for the preparation of 1-cyclopentyl-6-[(3,4-trans)-4-methyl-1-(pyridin-3-ylmethyl)pyrrolidin-3-yl]-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one but substituting 1-cyclopentyl-6-[(3S,4S)-4-methylpyrrolidin-3-yl]-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one and 1-methyl-1H-benzo[d]imidazole-2-carbaldehyde provided the title compound. 400 MHz 1H NMR (CDCl3) δ 7.98 (s, 1H), 7.73 (m, 1H), 7.35 (dd, J=7.1, 1.2 Hz, 1H), 7.29-7.21 (m, 2H), 5.13-5.09 (m, 1H), 4.11-4.06 (m, 2H), 3.97 (s, 3H), 3.37 (t, J=8.3 Hz, 1H), 3.06 (d, J=10.4 Hz, 1H), 2.88-2.85 (m, 1H), 2.77-2.73 (m, 1H), 2.16-1.92 (m, 8H), 1.70-1.66 (m, 2H), 1.21 (d, J=7.1 Hz, 3H). MS: (M+H m/z=432.1).

Quellen und Nachweise

ORD-Eintrag
ord-42ab9a4662074ee4bed590bc01105785
Quelldatensatz
uspto-grants-2011_06
Patentnummer
US07964607B2

Notizen zur Reaktion

Wird geladen…